Neuropsychiatric complications of epilepsy

Handbook of Clinical Neurology

Volumn 107, Issue , 2012, Pages 461-482

  Kanner, Andres M ^a   Hesdorffer, Dale C ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865580627     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52898-8.00037-9     Document Type: Chapter

References (237)

1. Adachi N., Kato M., Sekimoto M., et al. Recurrent postictal psychosis after remission of interictal psychosis: further evidence of bimodal psychosis. Epilepsia 2003, 44:1218-1222.
2. Alper K., Devinsky O., Westbrook L., et al. Premorbid psychiatric risk factors for postictal psychosis. J Neuropsychiatry Clin Neurosci 2001, 13:492-499.
3. Alper K., Schwartz K.A., Kolts R.L., et al. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007, 62:345-354.
4. Alwash R.H., Hussein M.J., Matloub F.F. Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan. Seizure 2000, 9:412-416.
5. Andermann L.F., Savard G., Meencke H.J., et al. Psychosis after resection of ganglioglioma or DNET: evidence for an association. Epilepsia 1999, 40:83-87.
6. Andrade R., Nicoll R.A. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 1987, 394:99-124.
7. Annegers J.F., Hauser W.A., Elveback L.R., et al. The risk of epilepsy following febrile convulsions. Neurology 1979, 29:297-303.
8. Anson J.A., Kuhlman D.T. Postictal Kluver-Bucy syndrome after temporal lobectomy. J Neurol Neurosurg Psychiatry 1993, 56:311-313.
9. Applegate C.D., Tecott L.H. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol 1998, 154:522-530.
10. Arbatova J., D'Amato E., Vaarmann A., et al. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy. Epilepsia 2005, 46:49-51.
11. Austin J.K., Harezlak J., Dunn D.W., et al. Behavior problems in children before first recognized seizures. Pediatrics 2001, 107:115-122.
12. Aznar S., Qian Z., Shah R., et al. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 2003, 959:58-67.
13. Baetz M., Bowen R.C. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry 1998, 43:73-77.
14. Baker G.A., Spector S., McGrath Y., et al. Impact of epilepsy in adolescence: a UK controlled study. Epilepsy Behav 2005, 6:556-562.
15. Ban T.A., Vartanian F.E., Sartorius N., et al. Identification of high-risk criteria in the framework of W.H.O. collaborative research in the major mental disorders. Prog Neuropsychopharmacol 1979, 3:575-578.
16. Bartlet J.E. Chronic psychosis following epilepsy. Am J Psychiatry 1957, 114:338-343.
17. Beck S.G., Choi K.C. 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance. Neurosci Lett 1991, 133:93-96.
18. Beghi E., Spagnoli P., Airoldi L., et al. Emotional and affective disturbances in patients with epilepsy. Epilepsy Behav 2002, 3:255-261.
19. Ben-Menachem E., Persson L.I., Hedner T. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin. Epilepsy Res 1992, 11:45-49.
20. Berman R.M., Cappiello A., Anand A., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47:351-354.
21. Bhagwagar Z., Whale R., Cowen P.J. State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 2002, 180:24-28.
22. Blackwood D.H.R., Cull R.E., Freeman C.P., et al. A study of the incidence of epilepsy following ECT. J Neurol Neurosurg Psychiatry 1980, 43:1098-1102.
23. Blanchet P., Frommer G.P. Mood change preceding epileptic seizures. J Nerv Ment Dis 1986, 174:471-476.
24. Bleuler E. Lehrbuch der Psychiatrie 1949, Springer, Berlin. 8th edn.
25. Blumer D., Altshuler L.L. Affective disorders. Epilepsy: A Comprehensive Textbook 1998, Vol. II:2083-2099. Lippincott-Raven, Philadelphia.
26. Blumer D., Zielinksi J. Pharmacologic treatment of psychiatric disorders associated with epilepsy. J Epilepsy 1988, 1:135-150.
27. Booij L., Van der Does W., Benkelfat C., et al. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 2002, 27:852-861.
28. Bouilleret V., Semah F., Biraben A., et al. Involvement of the basal ganglia in refractory epilepsy: an 18-F-fluoro-L-DOPA PET study using 2 methods of analysis. J Nucl Med 2005, 46:540-547.
29. Boylan L.S., Flint L.A., Labovitz D.L., et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62:258-261.
30. Bremmer M.A., Hoogendijk W.J., Deeg D.J., et al. Depression in older age is a risk factor for first ischemic cardiac events. Am J Geriatr Psychiatry 2006, 14:523-530.
31. Breslau N., Davis G.C., Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991, 37:11-23.
32. Breslau N., Schultz L.R., Stewart W.F., et al. Headache and major depression: is the association specific to migraine?. Neurology 2000, 54:308-313.
33. Briellmann R.S., Kalnins R.M., Hopwood M.J., et al. TLE patients with postictal psychosis: mesial dysplasia and anterior hippocampal preservation. Neurology 2000, 55:1027-1030.
34. Browning R.A., Clark K.B., Naritoku D.K., et al. Loss of anticonvulsant effect of vagus nerve stimulation in the pentylenetetrazol seizure model following treatment with 6-hydroxydopamine or 5,7-dihydroxy-tryptamine. Soc Neurosci 1997, 23:2424.
35. Browning R.A., Wood A.V., Merrill M.A., et al. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol 1997, 336:1-6.
36. Burcusa S.L., Iacono W.G. Risk for recurrence in depression. Clin Psychol Rev 2007, 27:959-985.
37. Caplan R., Siddarth P., Gurbani S., et al. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 2005, 46:720-730.
38. Carlton-Ford S., Miller R., Brown M., et al. Epilepsy and children's social and psychological adjustment. J Health Soc Behav 1995, 36:285-301.
39. Chang B.S., Lowenstein D.H. Epilepsy. N Engl J Med 2003, 349:1257-1266.
40. Chen B., Dowlatshahi D., MacQueen G.M., et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260-265.
41. Clinckers R., Smolders I., Meurs A., et al. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci Lett 2005, 390:48-53.
42. Cramer J.A., Blum M., Reed M., et al. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003, 4:515-521.
43. Cramer J.A., Blum D., Fanning K., et al. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004, 5:337-342.
44. Curran S., DePauw Selecting an antidepressant for use in a patient with epilepsy. Safety considerations. Drug Safe 1998, 18:125-133.
45. Dailey J.W., Yan Q.S., Mishra P.K., et al. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992, 260:533-540.
46. Daly D. Ictal affect. Am J Psychiatry 1958, 115:97-108.
47. Davis M. Functional neuroanatomy of anxiety and fear: a focus on the amygdala. Neurobiology of Mental Illness 1999, 463-474. Oxford University Press, New York. D.S. Charney, E.J. Nestler, B.S. Bunney (Eds.).
48. de Araujo Filho G.M., Pascalicchio T.F., Lin K., et al. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate. Epilepsy Behav 2006, 8:606-609.
49. Delgado P.L., Price L.H., Miller H.L., et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994, 51:865-874.
50. Delgado P.L., Miller H.L., Salomon R.M., et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999, 46:212-220.
51. Denhoff E., Laufer M.W., Solomon G. Hyperkinetic impulse disorder in children's behavior problems. Psychosom Med 1957, 19:38-49.
52. Devinsky O., Abrahmson H., Alper K., et al. Postictal psychosis: a case control study of 20 patients and 150 controls. Epilepsy Res 1995, 20:247-253.
53. Devinsky O., Barr W.B., Vickrey B.G., et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology 2005, 65:1744-1749.
54. Dominian J., Serafetinides E.A., Dewhurst M. A follow-up study of late-onset epilepsy. II. Psychiatric and social findings. Br Med J 1963, 1:431-435.
55. Drake M.E. Postictal Capgras syndrome. Clin Neurol Neurosurg 1987, 89:271-274.
56. Drevets W.C., Frank E., Price J.C., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999, 46:1375-1387.
57. Dube C.M., Brewster A.L., Richichi C., et al. Fever, febrile seizures and epilepsy. Trends Neurosci 2007, 30:490-496.
58. Dunn D.W., Kronenberger W.G. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol 2005, 12:222-228.
59. Dunn D.W., Austin J.K., Huster G.A. Behaviour problems in children with new-onset epilepsy. Seizure 1997, 6:283-287.
60. Edeh J., Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987, 151:95-101.
61. Ettinger A.B., Weisbrot D.M., Nolan E.E., et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998, 39:595-599.
62. Ettinger A.B., Reed M.L., Goldberg J.F., et al. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 2005, 65:535-540.
63. Fann J.R., Burington B., Leonetti A., et al. Psychiatric illness following traumatic brain injury in an adult health maintenance organization population. Arch Gen Psychiatry 2004, 61:53-61.
64. Favale E., Audenino D., Cocito L., et al. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003, 12:316-318.
65. Forsgren L., Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res 1990, 6:66-81.
66. Fromm G.H., Amores C.Y., Thies W. Imipramine in epilepsy. Arch Neurol 1972, 27:198.
67. Fromm G.H., Wessel H.B., Glass J.D., et al. Imipramine in absence and myoclonic-astatic seizures. Neurology 1978, 28:953.
68. Gaitatzis A., Trimble M.R., Sander J.W. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004, 110:207-220.
69. Gastaut H., Roger J., Lesèvre N. Différenciation psychologique des épileptiques en fonction des formes électrocliniques de leur maladie. Rev Psychol Appl 1953, 3:237-249.
70. Gastaut H., Morin G., Lesèvre N. Étude du comportement des épileptiques psychomoteurs dans l'intervalle de leurs crises: les troubles de l'activité globale et de la sociabilité. Ann Med Psychol (Paris) 1955, 113:1-27.
71. Geronimus A.T., Hicken M., Keene D., et al. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health 2006, 96:826-833.
72. Gilliam F., Kuzniecky R., Faught E., et al. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997, 38:233-236.
73. Gilliam F.G., Maton B.M., Martin R.C., et al. Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007, 68:364-368.
74. Glauss A. Ueber Kombinatiionen von Schizophrenia und Epilepsie. Z Ges Neurol Psychiatr 1931, 135:450-500.
75. Golden R.N., Heine A.D., Ekstrom R.D., et al. A longitudinal study of serotonergic function in depression. Neuropsychopharmacology 2002, 26:653-659.
76. Goldstein L.H., Holland L., Soteriou H., et al. Illness representations, coping styles and mood in adults with epilepsy. Epilepsy Res 2005, 67:1-11.
77. Graumlich J.F., McLaughlin R.G., Birkhahn D., et al. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur J Pharmacol 1999, 369:305-311.
78. Green W.H. The treatment of attention-deficit hyperactivity disorder with nonstimulant medications. Child Adolesc Psychiatr Clin N Am 1995, 4:169-195.
79. Harris J.C. Experimental animal modeling of depression and anxiety. Psychiatr Clin North Am 1989, 12:815-836.
80. Haselberger M.B., Freedman L.S., Tolbert S. Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 1997, 17:107-109.
81. Hasler G., Bonwetsch R., Giovacchini G., et al. 5-HT(1A) receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007, 62:1258-1264.
82. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993, 34:453-468.
83. Hemmer S.A., Pasternak J.F., Zecker S.G., et al. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001, 24:99-102.
84. Hermann B.P., Whitman S., Wyler A.R., et al. Psychosocial predictors of psychopathology in epilepsy. Br J Psychiatry 1990, 156:98-105.
85. Hermann B., Jones J., Dabbs K., et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 2007, 130:3135-3148.
86. Hernandez E.J., Williams P.A., Dudek F.E. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 2002, 43:1337-1345.
87. Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?. Epilepsia 2009, 50:978-988.
88. Hesdorffer D.C., Hauser W.A., Annegers J.F., et al. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000, 47:246-249.
89. Hesdorffer D.C., Ludvigsson P., Olafsson E., et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004, 61:731-736.
90. Hesdorffer D.C., Hauser W.A., Olafsson E., et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006, 59:35-41.
91. Hitiris N., Mohanraj R., Norrie J., et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75:192-196.
92. Holdsworth L., Whitmore K. A study of children with epilepsy attending ordinary schools. II: Information and attitudes held by their teachers. Dev Med Child Neurol 1974, 16:759-765.
93. Holtmann M., Becker K., Kentner-Figura B., et al. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2003, 44:1241-1244.
94. Hughes J.R., DeLeo A.J., Melyn M.A. The electroencephalogram in attention deficit-hyperactivity disorder: emphasis on epileptiform discharges. Epilepsy Behav 2000, 1:271-277.
95. Irwin K., Birch V., Lees J., et al. Multiple subpial transaction in Landau-Kleffner syndrome. Dev Med Child Neurol 2001, 43:248-252.
96. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 1992, 72:165-229.
97. Jacoby A., Baker G.A., Steen N., et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996, 37:148-161.
98. Jakus R., Graf M., Juhasz G., et al. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp Neurol 2003, 184:964-972.
99. Jalava M., Sillanpaa M. Concurrent illnesses in adults with childhood-onset epilepsy: a population-based 35-year follow-up study. Epilepsia 1996, 37:1155-1163.
100. Jensen I., Vaernet K. Temporal lobe epilepsy. Follow-up investigation of 74 temporal lobe resected patients. Acta Neurochir (Wien) 1977, 37:173-200.
101. Jobe P.C., Weber R.H. Affective disorder and epilepsy comorbidity in the genetically epilepsy prone-rat (GEPR). Neurologic Dysfunction in Depression 2005, 121-158. Taylor & Francis, London. F. Gilliam, A.M. Kanner, Y.I. Sheline (Eds.).
102. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000, 62:463-471.
103. Jones J.E., Watson R., Sheth R., et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 2007, 49:493-497.
104. Jung M.E., Lal H., Gatch M.B. The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci Biobehav Rev 2002, 26:429-439.
105. Kanemoto K., Miyamoto T., Abe R. Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure 1999, 8:364-366.
106. Kanemoto K., Tsuji T., Kawasaki J. Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification. Epilepsia 2001, 42:98-103.
107. Kanner A.M., Balabanov A.J. Psychiatric outcome of epilepsy surgery. Textbook of Epilepsy Surgery 2008, 1254-1262. Informa Healthcare, London. H.O. Luders (Ed.).
108. Kanner A.M., Ostrovskaya A. Long-term significance of postictal psychotic episodes I. Are they predictive of bilateral ictal foci?. Epilepsy Behav 2008, 12:150-153.
109. Kanner A.M., Stagno S., Kotagal P., et al. Postictal psychiatric events during prolonged video-electroencephalographic monitoring studies. Arch Neurol 1996, 53:258-263.
110. Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 2000, 1:100-105.
111. Kanner A.M., Soto A., Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 2004, 62:708-713.
112. Kanner A.M., Byrne R.W., Chicharro A.V., et al. Is a lifetime psychiatric history predictive of a worse postsurgical seizure outcome following a temporal lobectomy?. Neurology 2009, 72:793-799.
113. Kanner A.M., Barry J.J., Gilliam F., et al. Anxiety disorders, sub-syndromic depressive episodes and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?. Epilepsia 2010, 51:1152-1158.
114. Kaplan H.I., Sadock B.J. Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry 1991, Williams and Wilkins, Baltimore.
115. Kaplan P.W. Behavioral manifestations of nonconvulsive status epilepticus. Epilepsy Behav 2002, 3:122-139.
116. Kessler R.C., Zhao S., Katz S.J., et al. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry 1999, 156:115-123.
117. Ketter T.A., Malow B.A., Flamini R., et al. Anticonvulsant withdrawal-emergent psychopathology. Neurology 1994, 44:55-61.
118. Kilian M., Frey H.H. Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 1973, 12:681-692.
119. Kohler C.G., Carran M.A., Bilker W., et al. Association of fear auras with mood and anxiety disorders after temporal lobectomy. Epilepsia 2001, 42:674-681.
120. Koolhaas J.M., de Boer S.F., Buwalda B., et al. Individual variation in coping with stress: a multidimensional approach of ultimate and proximate mechanisms. Brain Behav Evol 2007, 70:218-226.
121. Kraepelin E. Psychiatrie 1923, Vol 3. Johann Ambrosius Barth, Leipzig.
122. Landau W.M., Kleffner F. Syndrome of acquired aphasia with convulsive disorder in children. Neurology 1957, 7:523-530.
123. Landolt H. Some clinical electroencephalographical correlations in epileptic psychosis (twilight states). Electroencephalogr Clin Neurophysiol 1953, 5:121.
124. Landolt H. Über Verstimmungen, Dämmerzustände und schizophrene Zustandsbilder bei Epilepsie: Ergebnisse klinischer und elektroenzephalographischer Untersuchungen. Schweiz Arch Neurol Psychiatrie 1955, 76:313-321.
125. Laufer M., Denhoff E. Hyperkinetic behavior in children. J Pediatr 1957, 50:463-474.
126. Lehrner J., Kalchmayr R., Serles W., et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999, 8:88-92.
127. Leinonen E., Tuunainen A., Lepola U. Postoperative psychoses in epileptic patients after temporal lobectomy. Acta Neurol Scand 1994, 90:394-399.
128. Lewis D.V., Barboriak D.P., MacFall J.R., et al. Do prolonged febrile seizures produce medial temporal sclerosis? Hypotheses, MRI evidence and unanswered questions. Prog Brain Res 2002, 135:263-278.
129. Lindsay J., Ounsted C., Richards P. Long-term outcome in children with temporal lobe seizures. V: indications and contra-indications for neurosurgery. Dev Med Child Neurol 1984, 26:25-32.
130. Livneh H., Wilson L.M., Duchesneau A., et al. Psychosocial adaptation to epilepsy: the role of coping strategies. Epilepsy Behav 2001, 2:533-544.
131. Logothetis J. Spontaneous epileptic seizures and EEG changes in the course of phenothiazine therapy. Neurology 1967, 17:869-877.
132. Logsdail S.J., Toone B.K. Postictal psychosis. A clinical and phenomenological description. Br J Psychiatry 1988, 152:246-252.
133. Lu K.T., Gean P.W. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 1998, 86:729-737.
134. Mace C.J., Trimble M.R. Psychosis following temporal lobe surgery: a report of six cases. J Neurol Neurosurg Psychiatry 1991, 54:639-644.
135. Maier M., Mellers J., Toone B., et al. Schizophrenia, temporal lobe epilepsy and psychosis: an in vivo magnetic resonance spectroscopy and imaging study of the hippocampus/amygdala complex. Psychol Med 2000, 30:571-581.
136. Malizia A.L., Cunningham V.J., Bell C.J., et al. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998, 55:715-720.
137. Mazarati A.M., Shin D., Kwon Y.S., et al. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 2009, 34:457-461.
138. McCurry L., Cronquist S. Pemoline and hepatotoxicity. Am J Psychiatry 1997, 154:713-714.
139. McDermott S., Coker A.L., Mani S., et al. A population-based analysis of behavior problems in children with cerebral palsy. J Pediatr Psychol 1996, 21:447-463.
140. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000, 886:172-189.
141. Mendez M.F., Cummings J.L., Benson D.F. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986, 43:766-770.
142. Mengod G., Pompeiano M., Martinez-Mir M.I., et al. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 1990, 524:139-143.
143. Mensah S.A., Beavis J.M., Thapar A.K., et al. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav 2007, 11:118-124.
144. Merlet I., Ostrowsky K., Costes N., et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 2004, 127:900-913.
145. Meschaks A., Lindstrom P., Halldin C., et al. Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Arch Neurol 2005, 62:946-960.
146. Mintzer S., Lopez F. Comorbidity of ictal fear and panic disorder. Epilepsy Behav 2002, 3:330-337.
147. Moreno F.A., Heninger G.R., McGahuey C.A., et al. Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol Psychiatry 2000, 48:327-329.
148. Moreno F.A., Rowe D.C., Kaiser B., et al. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 2002, 7:213-216.
149. Morrell F., Whisler W.W., Smith M.C., et al. Landau-Kleffner syndrome: treatment with subpial intracortical transection. Brain 1995, 118:1529-1546.
150. Mula M., Trimble M.R., Lhatoo S.D., et al. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003, 44:659-663.
151. Mula M., Trimble M.R., Sander J.W. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 2003, 44:1573-1577.
152. Mula M., Trimble M.R., Yuen A., et al. Psychiatric adverse events during levetiracetam therapy. Neurology 2003, 61:704-706.
153. Mula M., Sander J.W., Trimble M.R. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam. Seizure 2006, 15:405-408.
154. Mula M., Schmitz B., Jauch R., et al. On the prevalence of bipolar disorder in epilepsy. Epilepsy Behav 2008, 13:658-661.
155. Murakami T., Okada M., Kawata Y., et al. Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br J Pharmacol 2001, 134:507-520.
156. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539-7547.
157. Nilsson F.M., Kessing L.V., Bolwig T.G. On the increased risk of developing late-onset epilepsy for patients with major affective disorder. J Affect Disord 2003, 76:39-48.
158. Nissenkorn A., Moldavsky M., Loberboym M., et al. Postictal psychosis in a child. J Child Neurol 1999, 14:818-819.
159. Nutt D.J., Glue P., Lawson C.W., et al. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorders. Arch Gen Psychiatry 1990, 47:917-925.
160. O'Donoghue M.F., Goodridge D.M., Redhead K., et al. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999, 49:211-214.
161. Oguz A., Kurul S., Dirik E. Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. J Child Neurol 2002, 17:37-40.
162. Ohira T., Iso H., Satoh S., et al. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 2001, 32:903-908.
163. Okada M., Hirano T., Mizuno K., et al. Effects of carbamazepine on hippocampal serotonergic system. Epilepsy Res 1998, 31:187-198.
164. Okuhara D.Y., Beck S.G. 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J Neurophysiol 1994, 71:2161-2167.
165. Olfson M., Das A.K., Gameroff M.J., et al. Bipolar depression in a low-income primary care clinic. Am J Psychiatry 2005, 162:2146-2151.
166. Olnes M.J., Golding A., Kaplan P.W. Nonconvulsive status epilepticus resulting from benzodiazepine withdrawal. Ann Intern Med 2003, 139:956-958.
167. Ott D., Caplan R., Guthrie D., et al. Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. J Am Acad Child Adolesc Psychiatry 2001, 40:907-914.
168. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40:288-295.
169. Owens M.J., Morgan W.N., Plott S.J., et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997, 283:1305-1322.
170. Ownby R.L., Crocco E., Acevedo A., et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006, 63:530-538.
171. Patten S.B., Beck C.A., Williams J.V., et al. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524-1527.
172. Perrine K., Hermann B.P., Meador K.J., et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995, 52:997-1003.
173. Placidi G.P., Oquendo M.A., Malone K.M., et al. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 2001, 50:783-791.
174. Qin P., Xu H., Laursen T.M., et al. Risk for schizophrenia and schizophrenia-like psychosis among patientswith epilepsy: population based cohort study. BMJ 2005, 331:23.
175. Ramasubbu R., Tobias R., Buchan A.M., et al. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J Neuropsychiatry Clin Neurosci 2006, 18:96-99.
176. Regenold W.T., Weintraub D., Taller A. Electroconvulsive therapy for epilepsy and major depression. Am J Geriatr Psychiatry 1998, 6:180-183.
177. Riad M., Garcia S., Watkins K.C., et al. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000, 417:181-194.
178. Rickels K., Downing R., Schweizer E., et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993, 50:884-895.
179. Ried S., Mothersill I.W. Forced normalization: the clinical neurologist's view. Forced Normalization and Alternative Psychoses of Epilepsy 1998, 77-94. Wrightson Biomedical Publishing, Petersfield. M.R. Trimble, B. Schmitz (Eds.).
180. Ring H.A., Crellin R., Kirker S., et al. Vigabatrin and depression. J Neurol Neurosurg Psychiatry 1993, 56:925-928.
181. Robertson M. Depression in patients with epilepsy: an overview and clinical study. The Psychopharmacology of Epilepsy 1985, 65. John Wiley, Chichester. M. Trimble (Ed.).
182. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
183. Rosemarie K., Frank G., David J.T. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Healthstyles Survey. Epilepsia 2006, 47:1915-1921.
184. Rubinstein M., Cepeda C., Hurst R.S., et al. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 2001, 21:3756-3763.
185. Salaycik K.J., Kelly-Hayes M., Beiser A., et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke 2007, 38:16-21.
186. Salgado-Commissariat D., Alkadhi K.A. Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons. Neuropharmacology 1997, 36:1705-1712.
187. Sapolsky R.M., Uno H., Rebert C.S., et al. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990, 10:2897-2902.
188. Savic I., Lindstrom P., Gulyas B., et al. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62:1343-1351.
189. Schmitz B., Wolf P. Psychosis in epilepsy: frequency and risk factors. J Epilepsy 1995, 8:295-305.
190. Scott R.C., Gadian D.G., King M.D., et al. Magnetic resonance imaging findings within 5 days of status epilepticus in childhood. Brain 2002, 125:1951-1959.
191. Scott R.C., King M.D., Gadian D.G., et al. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003, 126:2551-2557.
192. Scott R.C., King M.D., Gadian D.G., et al. Prolonged febrile seizures are associated with hippocampal vasogenic edema and developmental changes. Epilepsia 2006, 47:1493-1498.
193. Seidman L.J., Pantelis C., Keshavan M.S., et al. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull 2003, 29:803-830.
194. Shaw P., Mellers J., Henderson M., et al. Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry 2004, 75:1003-1008.
195. Shaw P., Eckstrand K., Sharp W., et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 2007, 104:19649-19654.
196. Shaw P., Gornick M., Lerch J., et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007, 64:921-931.
197. Sheline Y.I. Brain structural changes associated with depression. Depression and Brain Dysfunction 2005, 85-104. Taylor & Francis, London. F. Gilliam, A.M. Kanner, Y.I. Sheline (Eds.).
198. Shiah I.S., Yatham L.N. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar Disord 2000, 2:77-92.
199. Slater E., Beard A.W., Glithero E. The schizophrenia-like psychosis of epilepsy. Br J Psychiatry 1963, 109:95-150.
200. Smith M.A., Makino S., Kvetnansky R., et al. Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci 1995, 771:234-239.
201. Sotelo C., Cholley B., El Mestikawy S., et al. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 1990, 2:1144-1154.
202. Southwick S.M., Vythilingam M., Charney D.S. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 2005, 1:255-291.
203. Spijker J., de Graaf R., Oldehinkel A.J., et al. Are the vulnerability effects of personality and psychosocial functioning on depression accounted for by subthreshold symptoms?. Depress Anxiety 2007, 24:472-478.
204. Stahl S.M. Depression and bipolar disorders. Essential Pharmacology: Neuroscientific Basis and Practical Applications 2000, 135-197. Cambridge University Press, New York. 2nd edn. S.M. Stahl (Ed.).
205. Stahl S.M. Antipsychotic agents. Essential Pharmacology: Neuroscientific Basis and Practical Applications 2000, 401-458. Cambridge University Press, New York. 2nd edn. S.M. Stahl (Ed.).
206. Stahl S.M. Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action?. J Clin Psychiatry 2004, 65:149-150.
207. Statnick M.A., Maring-Smith M.L., Clough R.W., et al. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci 1996, 59:1763-1771.
208. Stefansson S.B., Olafsson E., Hauser W.A. Psychiatric morbidity in epilepsy: a case controlled study of adults receiving disability benefits. J Neurol Neurosurg Psychiatry 1998, 64:238-241.
209. Stevens J.R. Psychiatric consequences of temporal lobectomy for intractable seizures: a 20-30-year follow-up of 14 cases. Psychol Med 1990, 20:529-545.
210. Swinkels J., Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol 1995, 9:19-25.
211. Tarulli A., Devinsky O., Alper K. Progression of postictal to interictal psychosis. Epilepsia 2001, 42:1468-1471.
212. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 2001, 132:1423-1430.
213. Tatarczynska E., Palucha A., Szewczyk B., et al. Anxiolytic and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Pol J Pharmacol 2002, 54:707-710.
214. Taylor D.C. Mental state and temporal lobe epilepsy. Epilepsia 1972, 13:727-765.
215. Tellenbach H. Epilepsie als Anfallsleiden und als Psychose: uber alternative Psychosen paranoiderpragung bei "forcierter Normalisierung" (Landolt) des Elektroencephalogramms Epilepttischer. Nervenarzt 1965, 36:190-202.
216. Tellez-Zenteno J.F., Patten S.B., Jette N., et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
217. Theodore W.H., Giovacchini G., Bonwetsch R., et al. The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia 2006, 47:499-503.
218. Thorup A., Waltoft B.L., Pedersen C.B., et al. Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol Med 2007, 37:479-484.
219. Tiihonen J., Nousiainen U., Hakola P., et al. EEG abnormalities associated with clozapine treatment (letter). Am J Psychiatry 1991, 148:1406.
220. Toczek M.T., Carson R.E., Lang L., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003, 60:749-756.
221. Tollefson G.D., Rosenbaum J.F. Selective serotonin reuptake inhibitors. Textbook of Psychopharmacology 1998, 219-237. American Psychiatric Association Press, Washington, DC. 2nd edn. A.F. Schatzberg, C.B. Nemeroff (Eds.).
222. Toth P., Frankenburg F.R. Clozapine and seizures: a review. Can J Psychiatry 1994, 39:236-238.
223. Tremblay L.K., Naranjo C.A., Graham S.J., et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 2005, 62:1228-1236.
224. Trimble M.R. Behaviour changes following temporal lobectomy, with special reference to psychosis. J Neurol Neurosurg Psychiatry 1992, 55:89-91.
225. Trimble M.R., Rusch N., Betts T., et al. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 2000, 9:249-254.
226. Trindade-Filho E.M., de Castro-Neto E.F., de Carvalho R.A., et al. Serotonin depletion effects on the pilocarpine model of epilepsy. Epilepsy Res 2008, 82:194-199.
227. Umbricht D., Degreef G., Barr W.B., et al. Postictal and chronic psychosis in patients with temporal lobe epilepsy. Am J Psychiatry 1995, 152:224-231.
228. Urstein A. Dementia praecox und ihre Stellung zum manisch-depressiven Irresein. Eine klinische Studie 1909, Urban und Schwarzenberg, Berlin.
229. VanLandingham K.E., Heinz E.R., Cavazos J.E., et al. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998, 43:413-426.
230. Versiani M., Cassano G., Perugi G., et al. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 2002, 63:31-37.
231. Vestergaard M., Pedersen C.B., Christensen J., et al. Febrile seizures and risk of schizophrenia. Schizophr Res 2005, 73:343-349.
232. Watanabe K., Minabe Y., Ashby C.R., et al. Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats. Eur J Pharmacol 1998, 350:181-188.
233. Whitworth A.B., Fleischhacker W.W. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol 1995, 9:21-27.
234. Williams R.L. A note on robust variance estimation for cluster-correlated data. Biometrics 2000, 56:645-646.
235. Williams J., Griebel M.L., Dykman R.A. Neuropsychological patterns in pediatric epilepsy. Seizure 1998, 7:223-228.
236. Williams J., Steel C., Sharp G.B., et al. Anxiety in children with epilepsy. Epilepsy Behav 2003, 4:729-732.
237. Wolf P., Trimble M.R. Biological antagonism and epileptic psychosis. Br J Psychiatry 1985, 146:272-276.